Newsletter - Banner

Breadcrumb

Asset Publisher

angle-left RI-MUHC trainee earns prestigious MITACS fellowship

Congratulations to Catherine Argyriou!

Catherine Argyriou, PhD, is a trainee in the Child Health and Human Development Program at the Research Institute of the MUHC
Catherine Argyriou, PhD, is a trainee in the Child Health and Human Development Program at the Research Institute of the MUHC

Source: RI-MUHC. In 2017, as a doctoral student at the Research Institute of the McGill University Health Centre (RI-MUHC), Catherine Argyriou, PhD, and her supervisor, Dr. Nancy Braverman, won the AmorChem KNOCK OUT in Quebec City. The prize was seed funding for their project, “Retinal gene augmentation for peroxisome biogenesis disorders (REGAIN),” which aims to advance therapy for vision.

In 2020 Catherine has chalked up another win: the prestigious Mitacs Elevate Postdoctoral Fellowship. This fellowship allows her to participate in a research management training program while working with Dr. Braverman and venture capital fund AmorChem Therapeutics to advance gene therapy for PEX1-mediated Zellweger Spectrum Disorder (ZSD).

“I am so thrilled to continue developing this project,” says Catherine, “to continue working closely with our academic colleagues and our investors at AmorChem, and to pursue the professional development opportunities offered through Mitacs. This collaboration will bring a potentially sight-saving therapy one giant step closer to ZSD patients.”

Related news

Champion of the 2017 AmorChem KNOCK OUT event: Team Braverman!

Oct. 8, 2020